10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBOTT LABORATORIES | |||
Ticker: ABT Fiscal Year: 2017 | |||
Consolidated Statement of Cash Flows | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 16, 2018) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | |
| Cash Flow From (Used in) Operating Activities: | |||
| Net earnings | $ 477 | 1,400 | 4,423 |
| Adjustments to reconcile earnings to net cash from operating activities - | |||
| Depreciation | 1,046 | 803 | 871 |
| Amortization of intangible assets | 1,975 | 550 | 601 |
| Share-based compensation | 406 | 310 | 292 |
| Impact of currency devaluation | 480 | ||
| Amortization of inventory step-up | 907 | ||
| Investing and financing (gains) losses, net | 47 | 86 | (18) |
| Amortization of bridge financing fees | 5 | 165 | |
| Gains on sale of businesses | (1,163) | (25) | (2,840) |
| Mylan N.V. equity investment adjustment | 947 | ||
| Gain on sale of Mylan N.V. shares | (45) | (207) | |
| Trade receivables | (207) | (177) | (171) |
| Inventories | 249 | (98) | (257) |
| Prepaid expenses and other assets | 109 | 113 | 57 |
| Trade accounts payable and other liabilities | 615 | (652) | (742) |
| Income taxes | 1,149 | (699) | 957 |
| Net Cash From Operating Activities | 5,570 | 3,203 | 2,966 |
| Cash Flow From (Used in) Investing Activities: | |||
| Acquisitions of property and equipment | (1,135) | (1,121) | (1,110) |
| Acquisitions of businesses and technologies, net of cash acquired | (17,183) | (80) | (235) |
| Proceeds from business dispositions | 6,042 | 25 | 230 |
| Proceeds from the sale of Mylan N.V. shares | 2,704 | 2,290 | |
| Purchases of investment securities | (210) | (2,823) | (4,933) |
| Proceeds from sales of investment securities | 129 | 3,709 | 4,112 |
| Other | 35 | 42 | 52 |
| Net Cash From (Used in) Investing Activities | (9,618) | (248) | 406 |
| Cash Flow From (Used in) Financing Activities: | |||
| Proceeds from issuance of (repayments of) short-term debt and other | (1,034) | (1,767) | (1,281) |
| Proceeds from issuance of long-term debt and debt with maturities over 3 months | 6,742 | 14,934 | 2,485 |
| Repayments of long-term debt and debt with maturities over 3 months | (8,650) | (12) | (57) |
| Payment of bridge financing fees | (170) | ||
| Purchase of Alere preferred stock | (710) | ||
| Acquisition and contingent consideration payments related to business acquisitions | (13) | (25) | (17) |
| Purchases of common shares | (117) | (522) | (2,237) |
| Proceeds from stock options exercised | 350 | 248 | 314 |
| Dividends paid | (1,849) | (1,539) | (1,443) |
| Net Cash From (Used in) Financing Activities | (5,281) | 11,147 | (2,236) |
| Effect of exchange rate changes on cash and cash equivalents | 116 | (483) | (198) |
| Net (Decrease) Increase in Cash and Cash Equivalents | (9,213) | 13,619 | 938 |
| Cash and Cash Equivalents, Beginning of Year | 18,620 | 5,001 | |
| Cash and Cash Equivalents, End of Year | 9,407 | 18,620 | 5,001 |
| Supplemental Cash Flow Information: | |||
| Income taxes paid | 570 | 620 | 631 |
| Interest paid | 917 | 181 | 166 |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2017 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |